Literature DB >> 11506898

Identification, quantification and fine structural characterization of glycosaminoglycans from uterine leiomyoma and normal myometrium.

T N Mitropoulou1, A D Theocharis, K D Stagiannis, N K Karamanos.   

Abstract

The type, amount and fine chemical composition of glycosaminoglycans (GAGs) present both in human normal myometrium and uterine leiomyoma have been studied. GAGs were fractionated by ion-exchange chromatography on DEAE-Sephacel, isolated by gel-permeation chromatography on Sepharose CL-6B and characterized using electrophoresis in cellulose acetate membranes, specific enzymic treatments and analysis by high-performance capillary electrophoresis (HPCE). No statistical intrabatch differences in total GAG content in both tissues were identified, whereas significant interbatch differences between normal myometrium and uterine leiomyoma were recorded. Hyaluronan (HA), chondroitin sulphate (CS), dermatan sulphate (DS), heparan sulphate (HS) and keratan sulphate (KS) were identified in both tissues. Statistically significant (P </= 0.001) differences in uterine leiomyoma in the content of HA (-27.7%), DS (+158.5%), KS (+116.4%) and HS (-52.5%), as compared to normal myometrium, were determined. Despite the differences in the amount of GAGs, no significant differences in the fine chemical composition of CS and DS were identified. It is worth noting that DS of both tissues is constructed by glucuronic acid-containing long repeats separated by a few iduronic acid residues. The results of this study suggest that the development of uterine leiomyoma is closely related to quantitative changes at the GAG level. The increase of DS and KS may well be related to increased neosynthesis of fibrotic connective tissue, whereas the decrease of HA and the unaltered amounts of CS may also indicate benign tumors of low growth rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506898     DOI: 10.1016/s0300-9084(01)01281-0

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

1.  Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma.

Authors:  John M Norian; Carter M Owen; Juan Taboas; Casey Korecki; Rocky Tuan; Minnie Malik; William H Catherino; James H Segars
Journal:  Matrix Biol       Date:  2011-09-24       Impact factor: 11.583

2.  Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Authors:  Caitlin Fujisawa; John J Castellot
Journal:  J Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.782

3.  Integrin β1 regulates leiomyoma cytoskeletal integrity and growth.

Authors:  Minnie Malik; James Segars; William H Catherino
Journal:  Matrix Biol       Date:  2012-09-26       Impact factor: 11.583

4.  A role for versican in the development of leiomyosarcoma.

Authors:  Paul A Keire; Steven L Bressler; Joan M Lemire; Badreddin Edris; Brian P Rubin; Maziar Rahmani; Bruce M McManus; Matt van de Rijn; Thomas N Wight
Journal:  J Biol Chem       Date:  2014-10-15       Impact factor: 5.157

5.  Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas.

Authors:  John M Norian; Minnie Malik; Candace Y Parker; Doina Joseph; Phyllis C Leppert; James H Segars; William H Catherino
Journal:  Reprod Sci       Date:  2009-08-21       Impact factor: 3.060

6.  Mechanical homeostasis is altered in uterine leiomyoma.

Authors:  Rebecca Rogers; John Norian; Minnie Malik; Gregory Christman; Mones Abu-Asab; Faye Chen; Casey Korecki; James Iatridis; William H Catherino; Rocky S Tuan; Namisha Dhillon; Phyllis Leppert; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2008-04       Impact factor: 8.661

Review 7.  The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer.

Authors:  Adam Pudełko; Grzegorz Wisowski; Krystyna Olczyk; Ewa Maria Koźma
Journal:  FEBS J       Date:  2019-02-05       Impact factor: 5.542

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.